MDL 72222

Known as: MDL-72222 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Phencyclidine and ketamine (but not other NMDA channel blockers, such as memantine) produce psychotomimetic effects. Since unlike… (More)
Is this relevant?
2005
2005
The present study was performed to examine neuroprotective effects of 5-hydroxytryptamine (5-HT)(3) receptor antagonists against… (More)
Is this relevant?
2001
2001
Rationale: It has previously been demonstrated that the 5-HT3 receptors located in the mesolimbic brain areas are able to… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2000
2000
BACKGROUND Previous studies indicated that, under continuous access conditions, the 5-HT3 antagonist MDL 72222 (MDL) effectively… (More)
Is this relevant?
1994
1994
Ethanol-dependent mice were treated with the 5-HT3 antagonist MDL 72222 after withdrawal from ethanol. Treatment with unit doses… (More)
Is this relevant?
1994
1994
The subtype-selective serotonin 5-HT3 antagonists MDL 72222 and ICS 205-930 were tested for their ability to modify nicotine self… (More)
Is this relevant?
1993
1993
The effects of three serotonin [5-hydroxytryptamine (5-HT)] receptor antagonists on cocaine self-administration behavior were… (More)
Is this relevant?
1991
1991
The effect of the selective 5-HT3 receptor antagonist MDL 72222 on voluntary ethanol consumption was examined in Sardinian… (More)
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Functional serotonin (5-hydroxytryptamine, 5-HT) receptors have been divided into three subtypes: 5-HT1,-like, 5-HT2 and 5-HT3… (More)
Is this relevant?
Highly Cited
1984
Highly Cited
1984
The properties of MDL 72222 (1αH,3α,5αH-tropan-3-yl-3,5-dichlorobenzoate), a novel compound with potent and selective blocking… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?